The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The approval is for Cytomegalovirus, a type of Herpes virus
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
It is the world’s first DNA-based Covid vaccine
Gini Health works in the domain of personalised healthcare
Acute therapies continue to report strong growth compared to chronic ones.
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
